<HTML>
<HEAD>
<META NAME="Generator" CONTENT="Microsoft Word 97">
<TITLE>FORM 8-K</TITLE>
<META NAME="Template" CONTENT="C:\Program Files\Microsoft Office\Office\html.dot">
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">

<FONT FACE="CG Times,Times New Roman"><P>&nbsp;</P>
<B><P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION</P>
<P ALIGN="CENTER">Washington, D.C. 20549</P>
<P ALIGN="CENTER">FORM 8-K</P>
<P ALIGN="CENTER">CURRENT REPORT</P>
</B><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</P>
<P ALIGN="CENTER">Date of Report (Date of earliest event reported): April 29, 2004</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mediware Information Systems, Inc.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
</U></FONT><FONT FACE="CG Times,Times New Roman" SIZE=2>(Exact name of registrant as specified in its charter)</P>
</FONT><FONT FACE="CG Times,Times New Roman"><P>&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=637>
<TR><TD VALIGN="TOP" COLSPAN=4>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New York&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1-10768&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11-2209324&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(State or other jurisdiction<BR>
of incorporation)</FONT></TD>
<TD WIDTH="29%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(Commission File Number)</FONT></TD>
<TD WIDTH="38%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=2><P ALIGN="CENTER">(IRS Employer<BR>
Identification No.)</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>
<P ALIGN="CENTER">&nbsp;</P>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11711 West 79th Street, Lenexa, KS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;66214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR><TD WIDTH="65%" VALIGN="TOP" COLSPAN=3>
<FONT SIZE=2><P ALIGN="CENTER">(Address of principal executive offices)</FONT></TD>
<TD WIDTH="35%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(Zip Code)</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>
<P>&nbsp;</TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>
<FONT FACE="CG Times,Times New Roman"><P ALIGN="CENTER">Registrant's telephone number, including area code<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(913) 307-1000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="CG Times,Times New Roman"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">______________________________________________________________________________</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>Item 7. &nbsp;&nbsp;<U>Financial Statements, Pro Forma Financial Information and Exhibits.</P>
<OL TYPE="a">
<OL TYPE="a">

</U><LI>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements of Businesses Acquired.</LI>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None.</P>
<LI>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pro Forma Financial Information.</LI>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None.</P>
<LI>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.</LI></OL>
</OL>
<DIR>
<DIR>

<P ALIGN="JUSTIFY">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release, dated April 29, 2004, issued by Mediware Information<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Systems, Inc.</P>
<P>&nbsp;</P></DIR>
</DIR>

<P>Item 9. &nbsp;&nbsp;<U>Regulation FD Disclosure (pursuant to Item 12)</P><DIR>
<DIR>

</U><P>The following information is furnished pursuant to Item 12, "Results of Operations and Financial Condition" in accordance with SEC Release No. 33-8216.</P>
<P>On April 29, 2004, Mediware Information Systems, Inc. issued a press release announcing its financial results for the fiscal quarter ended March 31, 2004. A copy of the press release is furnished as Exhibit 99.1 to this report.</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P></DIR>
</DIR>

<B><P ALIGN="CENTER">SIGNATURES</P>
</B><P>&nbsp;</P>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P>&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=614>
<TR><TD WIDTH="45%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="55%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>MEDIWARE INFORMATION SYSTEMS, INC</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="55%" VALIGN="TOP">
<P>&nbsp;</TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>Date:&#9;April 29, 2004</FONT></TD>
<TD WIDTH="55%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>By:&nbsp;&nbsp;<U>/s/ George J. Barry<BR>
</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;George J. Barry<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="CG Times,Times New Roman"><P ALIGN="CENTER">&nbsp;</P>
<P>&nbsp;</P>
<B><U><P ALIGN="CENTER">EXHIBIT INDEX</P>
</B></U><P>&nbsp;</P>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a list of Exhibits furnished with this report.</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=637>
<TR><TD WIDTH="31%" VALIGN="TOP">
<U><FONT FACE="CG Times,Times New Roman"><P>Exhibit No.</U><BR>
</FONT></TD>
<TD WIDTH="69%" VALIGN="TOP">
<U><FONT FACE="CG Times,Times New Roman"><P>Description<BR>
</U></FONT></TD>
</TR>
<TR><TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>99.1</FONT></TD>
<TD WIDTH="69%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>Press Release, dated April 29, 2004, issued by Mediware Information Systems, Inc.</FONT></TD>
</TR>
</TABLE>

<FONT FACE="CG Times,Times New Roman"><P>&nbsp;</P>
<P>&nbsp;</P>
<B><P ALIGN="RIGHT">EXHIBIT 99.1</P>
</B><P>&nbsp;</P>
<P>&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=533>
<TR><TD WIDTH="25%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>Contact<BR>
</U><BR>
</B></FONT></TD>
<TD WIDTH="3%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="40%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>George Barry<BR>
913/307-1000<BR>
www.mediware.com</B></U></FONT></TD>
<TD WIDTH="32%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>Thomas Redington<BR>
203/222-7399<BR>
212/926-1733<BR>
www.redingtoninc.com</B></U></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<B><P ALIGN="CENTER">&nbsp;</P><DIR>
<DIR>
<DIR>

<U><P ALIGN="CENTER">Mediware Reports Third Quarter Results</P>
</U><I><P ALIGN="CENTER">Record Revenue: Higher Costs - New Product Rollouts</P>
</B></I><P ALIGN="JUSTIFY">&nbsp;</P>
<B><P ALIGN="JUSTIFY">LENEXA, KS APR. 29, 2004 -- </B>Mediware Information Systems, Inc. (Nasdaq: MEDW) reported record revenue related to new product rollouts for the third fiscal quarter ended March 31, 2004 of $9.3 million, a 14 percent increase over the year ago period. This is the Company's 13<SUP>th</SUP> consecutive quarter of revenue growth.</P>
<P ALIGN="JUSTIFY">Operating income for the quarter just ended was $840,000 versus $1.6 million in the third quarter of the prior fiscal year. </P>
<P ALIGN="JUSTIFY">Net income for the quarter just ended was $561,000, or 7 cents per basic share and 7 cents per fully diluted share, compared to net income in the year-ago third quarter of $999,000, or 14 cents per basic share and 13 cents per fully diluted share. </P>
<P ALIGN="JUSTIFY">Commenting on the quarter, George Barry, Mediware's CEO said, "Introductions of our new pharmacy and blood banking products are experiencing strong customer interest. The Company has increased support costs in anticipation of the market rollout of these new products. Early phase revenues and the required buildup of support costs resulted in lower operating income in the March quarter. We anticipate strong revenue growth in future periods as the rollout advances."</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P></DIR>
</DIR>
</DIR>

<P ALIGN="CENTER"><CENTER><TABLE BORDER CELLSPACING=1 CELLPADDING=7 WIDTH=582>
<TR><TD VALIGN="TOP" COLSPAN=5>
<B><P ALIGN="CENTER">Third Quarter and First Nine Months <BR>
Fiscal 2004 and 2003 <BR>
Operating Statement Highlights<BR>
(in thousands) (unaudited)</B></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=5>
<P>&nbsp;</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP" HEIGHT=66><P></P></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=66>
<P ALIGN="CENTER">Three Months<BR>
Ended<BR>
March 31,</TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=2 HEIGHT=66>
<P ALIGN="CENTER">Nine Months<BR>
Ended<BR>
March 31,</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP" HEIGHT=22><P></P></TD>
<TD WIDTH="12%" VALIGN="MIDDLE" HEIGHT=22>
<P ALIGN="CENTER">2004</TD>
<TD WIDTH="12%" VALIGN="MIDDLE" HEIGHT=22>
<P ALIGN="CENTER">2003</TD>
<TD WIDTH="12%" VALIGN="MIDDLE" HEIGHT=22>
<P ALIGN="CENTER">2004</TD>
<TD WIDTH="13%" VALIGN="MIDDLE" HEIGHT=22>
<P ALIGN="CENTER">2003</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P>&nbsp;</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P>&nbsp;</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P>&nbsp;</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<P>&nbsp;</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="MIDDLE">
<P>&nbsp;&nbsp;System Sales</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ 3,333</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ 2,898</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ &nbsp;9,173</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ &nbsp;9,493</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="MIDDLE">
<P>&nbsp;&nbsp;Services</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ 5,987</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ 5,289</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$18,267</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$14,685</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="MIDDLE">
<P>Total Revenue</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ 9,320</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ 8,187</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$27,440</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$24,178</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="MIDDLE">
<P>&nbsp;&nbsp;Operating Expenses</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ 8,480</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ 6,556</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$23,217</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$19,594</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="MIDDLE">
<P>&nbsp;&nbsp;Proceeds from Settlement</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">($&nbsp;&nbsp;&nbsp;614)</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="MIDDLE">
<P>Operating Income</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp; 840 </TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$ 1,631 </TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp; 4,223 </TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp; 5,198 </TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="MIDDLE">
<P>Net Income</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp; 561</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp; 999 </TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp; 2,732</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp; 3,220</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="MIDDLE">
<P>Earnings Per Common Share - Basic</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp; 0.07</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp; 0.14</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp; 0.37</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp; 0.44</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<P>Earnings Per Common Share- Diluted</TD>
<TD WIDTH="12%" VALIGN="TOP">
<P ALIGN="RIGHT">$&nbsp;&nbsp; 0.07</TD>
<TD WIDTH="12%" VALIGN="TOP">
<P ALIGN="RIGHT">$&nbsp;&nbsp; 0.13</TD>
<TD WIDTH="12%" VALIGN="TOP">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp; 0.33</TD>
<TD WIDTH="13%" VALIGN="TOP">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp; 0.41</TD>
</TR>
</TABLE>
</CENTER></P>

<P ALIGN="CENTER"></P>
<P ALIGN="CENTER"><CENTER><TABLE BORDER CELLSPACING=1 CELLPADDING=7 WIDTH=556>
<TR><TD VALIGN="TOP" COLSPAN=3>
<B><P ALIGN="CENTER">Third Quarter <BR>
Fiscal 2004 and 2003 <BR>
Condensed Balance Sheet Highlights<BR>
(in thousands) (unaudited)</B></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=3>
<P>&nbsp;</TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=66><P></P></TD>
<TD WIDTH="48%" VALIGN="TOP" COLSPAN=2 HEIGHT=66>
<P ALIGN="CENTER">As of the Period Ended<BR>
March 31,</TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=22><P></P></TD>
<TD WIDTH="23%" VALIGN="MIDDLE" HEIGHT=22>
<P ALIGN="CENTER">2004</TD>
<TD WIDTH="25%" VALIGN="MIDDLE" HEIGHT=22>
<P ALIGN="CENTER">2003</TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">
<P>Cash and Cash Equivalents</TD>
<TD WIDTH="23%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;9,171</TD>
<TD WIDTH="25%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;5,877</TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">
<P>Working Capital</TD>
<TD WIDTH="23%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;8,162</TD>
<TD WIDTH="25%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;2,796</TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">
<P>Stockholders' Equity</TD>
<TD WIDTH="23%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;28,302</TD>
<TD WIDTH="25%" VALIGN="MIDDLE">
<P ALIGN="RIGHT">$&nbsp;22,325</TD>
</TR>
</TABLE>
</CENTER></P>

<P ALIGN="JUSTIFY">&nbsp;</P><DIR>
<DIR>
<DIR>

<P ALIGN="JUSTIFY">Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include HEMOCARE LifeLine<FONT FACE="Symbol">&auml;</FONT> , Hemocare&reg;, LifeLine&reg;, LifeTrak&reg;, and HCLL&trade; (blood bank), WORx&reg;, MediMAR&trade;, MediCOE&trade;, Pharmakon&reg;, and Digimedics&trade; (pharmacy), Surgiware&trade;, and Perioperative Solutions&trade; (operating room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.</P>
<P ALIGN="CENTER">#&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;#</P>
<I><FONT FACE="CG Times,Times New Roman"><P ALIGN="JUSTIFY">Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2003, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements. </P>
</I></FONT><P ALIGN="JUSTIFY">04/29/04</P></DIR>
</DIR>
</DIR>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "form8kapril04.htm", "secsgml_size_bytes": 16682}]
{"company-data": {"conformed-name": "MEDIWARE INFORMATION SYSTEMS INC", "cik": "0000874733", "assigned-sic": "7373", "irs-number": "112209324", "state-of-incorporation": "NY", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-10768", "film-number": "04766641"}, "business-address": {"street1": "11711 W 79TH STREET", "city": "LENEXA", "state": "KS", "zip": "11747", "phone": "5164237800"}, "mail-address": {"street1": "1121 OLD WALT WHITMAN RD", "city": "MELVILLE", "state": "NY", "zip": "11747-3005"}}
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2004
Mediware Information Systems, Inc.
(Exact name of registrant as specified in its charter)
New York                                 1-10768                                 11-2209324
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
11711 West 79th Street, Lenexa, KS                                            66214
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code
(913) 307-1000
______________________________________________________________________________
Item 7.
Financial Statements, Pro Forma Financial Information and Exhibits.
Financial Statements of Businesses Acquired.
None.
Pro Forma Financial Information.
None.
Exhibits.
99.1        Press Release, dated April 29, 2004, issued by Mediware Information
Systems, Inc.
Item 9.
Regulation FD Disclosure (pursuant to Item 12)
The following information is furnished pursuant to Item 12, "Results of Operations and Financial Condition" in accordance with SEC Release No. 33-8216.
On April 29, 2004, Mediware Information Systems, Inc. issued a press release announcing its financial results for the fiscal quarter ended March 31, 2004. A copy of the press release is furnished as Exhibit 99.1 to this report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDIWARE INFORMATION SYSTEMS, INC
Date:	April 29, 2004
By:
/s/ George J. Barry
George J. Barry
Chief Executive Officer
EXHIBIT INDEX
The following is a list of Exhibits furnished with this report.
Exhibit No.
Description
99.1
Press Release, dated April 29, 2004, issued by Mediware Information Systems, Inc.
EXHIBIT 99.1
Contact
George Barry
913/307-1000
www.mediware.com
Thomas Redington
203/222-7399
212/926-1733
www.redingtoninc.com
Mediware Reports Third Quarter Results
Record Revenue: Higher Costs - New Product Rollouts
LENEXA, KS APR. 29, 2004 --
Mediware Information Systems, Inc. (Nasdaq: MEDW) reported record revenue related to new product rollouts for the third fiscal quarter ended March 31, 2004 of $9.3 million, a 14 percent increase over the year ago period. This is the Company's 13
th
consecutive quarter of revenue growth.
Operating income for the quarter just ended was $840,000 versus $1.6 million in the third quarter of the prior fiscal year.
Net income for the quarter just ended was $561,000, or 7 cents per basic share and 7 cents per fully diluted share, compared to net income in the year-ago third quarter of $999,000, or 14 cents per basic share and 13 cents per fully diluted share.
Commenting on the quarter, George Barry, Mediware's CEO said, "Introductions of our new pharmacy and blood banking products are experiencing strong customer interest. The Company has increased support costs in anticipation of the market rollout of these new products. Early phase revenues and the required buildup of support costs resulted in lower operating income in the March quarter. We anticipate strong revenue growth in future periods as the rollout advances."
Third Quarter and First Nine Months
Fiscal 2004 and 2003
Operating Statement Highlights
(in thousands) (unaudited)
Three Months
Ended
March 31,
Nine Months
Ended
March 31,
2004
2003
2004
2003
System Sales
$ 3,333
$ 2,898
$  9,173
$  9,493
Services
$ 5,987
$ 5,289
$18,267
$14,685
Total Revenue
$ 9,320
$ 8,187
$27,440
$24,178
Operating Expenses
$ 8,480
$ 6,556
$23,217
$19,594
Proceeds from Settlement
$        0
$        0
$         0
($   614)
Operating Income
$    840
$ 1,631
$  4,223
$  5,198
Net Income
$    561
$    999
$  2,732
$  3,220
Earnings Per Common Share - Basic
$   0.07
$   0.14
$    0.37
$    0.44
Earnings Per Common Share- Diluted
$   0.07
$   0.13
$    0.33
$    0.41
Third Quarter
Fiscal 2004 and 2003
Condensed Balance Sheet Highlights
(in thousands) (unaudited)
As of the Period Ended
March 31,
2004
2003
Cash and Cash Equivalents
$   9,171
$   5,877
Working Capital
$   8,162
$   2,796
Stockholders' Equity
$ 28,302
$ 22,325
Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include HEMOCARE LifeLine
ä
, Hemocare®, LifeLine®, LifeTrak®, and HCLL™ (blood bank), WORx®, MediMAR™, MediCOE™, Pharmakon®, and Digimedics™ (pharmacy), Surgiware™, and Perioperative Solutions™ (operating room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.
#          #          #
Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2003, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.
04/29/04